Autoantibodies to GM1 and GQ1bα are not biological markers of alzheimer's disease

Journal of Alzheimer's Disease

Volumn 42, Issue 4, 2014, Pages 1165-1169

  Miura, Yumako ^a,b   Miyaji, Kazuki ^a   Chai, Yuek Ling ^a   Chen, Christopher L H ^a   Lai, Mitchell K P ^a   Yuki, Nobuhiro ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; anti ganglioside antibody; biological marker; ganglioside

Indexed keywords

AUTOANTIBODY; GANGLIOSIDE GM1 ANTIBODY; GANGLIOSIDE GQ 1B ANTIBODY; GANGLIOSIDE GQ 1BALPHA ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GANGLIOSIDE; GANGLIOSIDE GM1; GQ1BALPHA GANGLIOSIDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGED; ALZHEIMER DISEASE; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; MOTOR NEUROPATHY; MULTIINFARCT DEMENTIA; BLOOD; IMMUNOLOGY; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AUTOANTIBODIES; BIOLOGICAL MARKERS; DEMENTIA, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; G(M1) GANGLIOSIDE; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84907976847     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-140474     Document Type: Article

References (24)

1. Colasanti T, Barbati C, Rosano G, Malorni W, Ortona E (2010) Autoantibodies in patients with Alzheimer's disease: Pathogenetic role and potential use as biomarkers of disease progression. Autoimmun Rev 9, 807-811.
2. Kakio A, Nishimoto S, Yanagisawa K, Kozutsumi Y, Mat-suzaki K (2002) Interactions of amyloid (3-protein with various gangliosides in raft-like membranes: Importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry 41, 7385-7390.
3. Yanagisawa K, Odaka A, Suzuki N, Ihara Y (1995) GM1 ganglioside-bound amyloid (3-protein (A (3): A possible form of preamyloid in Alzheimer's disease. Nat Med 1, 1062-1066.
4. Mandal PK, Pettegrew JW (2004) Alzheimer's disease: NMR studies of asialo (GM1) and trisialo (GT1b) ganglioside interactions with A (3 (1-40) peptide in a membrane mimic environment. Neurochem Res 29, 447-453.
5. Schott K, Wormstall H, Dietrich M, Klein R, Batra A (1996) Autoantibody reactivity in serum of patients with Alzheimer's disease and other age-related dementias. Psychiatry Res 59, 251-254.
6. Hatzifilippou E, Koutsouraki E, Banaki T, Traka M, Costa VG, Baloyannis SJ (2008) Antibodies against GM1 in demented patients. Am J Alzheimers Dis Other Demen 23, 274-279.
7. Chapman J, Sela BA, Wertman E, Michaelson DM (1988) Antibodies to ganglioside GM1 in patients with Alzheimer's disease. Neurosci Lett 86, 235-240.
8. Foley P, Bradford HF, Docherty M, Fillit H, Luine VN, McEwen B, Bucht G, Winblad B, Hardy J (1988) Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer's disease. J Neurol 235, 466-471.
9. Chapman J, Bachar O, Korczyn AD, Wertman E, Michaelson DM (1988) Antibodies to cholinergic neurons in Alzheimer's disease. J Neurochem 51, 479-485.
10. Ariga T, Yanagisawa M, Wakade C, Ando S, Buccafusco JJ, McDonald MP, Yu RK (2010) Ganglioside metabolism in a transgenic mouse model of Alzheimer's disease: Expression of Chol-1a antigens in the brain. ASNNeuro 2, e00044.
11. Ariga T, Itokazu Y, McDonald MP, Hirabayashi Y, Ando S, Yu RK (2013) Brain gangliosides of a transgenic mouse model of Alzheimer's disease with deficiency in GD3-synthase: Expression of elevated levels of a cholinergic-specific gan-glioside, GT1aa. ASNNeuro 5, 141-148.
12. Ariga T, Kubota M, Nakane M, Oguro K, Yu RK, Ando S (2013) Anti-Chol-1 antigen, GQ1ba, antibodies are associated with Alzheimer's disease. PLoS One 8, e63326.
13. Vlam L, van der Pol WL, Cats EA, Straver DC, Piepers S, Franssen H, van den Berg LH (2012) Multifocal motor neuropathy: Diagnosis, pathogenesis and treatment strategies. Nat Rev Neurol 8, 48-58.
14. Yuki N, Hartung HP (2012) Guillain-Barre syndrome. NEngl J Med 366, 2294-2304.
15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
16. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Mas-deu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman Aetal. (1993) Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS-AIREN International Workshop. Neurology 43, 250-260.
17. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
18. Kapeller P, Barber R, Vermeulen RJ, Ader H, Scheltens P, Freidl W, Almkvist O, Moretti M, del Ser T, Vaghfeldt P, Enzinger C, Barkhof F, Inzitari D, Erkinjunti T, Schmidt R, Fazekas F (2003) Visual rating of age-related white matter changes on magnetic resonance imaging: Scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke 34, 441-445.
19. Hirabayashi Y, Nakao T, Irie F, Whittaker VP, Kon K, Ando S (1992) Structural characterization of a novel cholinergic neuron-specific ganglioside in bovine brain. J Biol Chem 267, 12973-12978.
20. Yuki N, Yoshino H, Sato S, Shinozawa K, Miyatake T (1992) Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies. Muscle Nerve 15, 899-903.
21. Landi G, D'Alessandro R, Dossi BC, Ricci S, Simone IL, Ciccone A (1993) Guillain-Barré syndrome after exogenous gangliosides in Italy. BMJ 307, 1463-1464.
22. Yuki N, Yamada M, Koga M, Odaka M, Susuki K, Tagawa Y, Ueda S, Kasama T, Ohnishi A, Hayashi S, Takahashi H, Kamijo M, Hirata K (2001) Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 49, 712-720.
23. Goodfellow JA, Bowes T, Sheikh K, Odaka M, Halstead SK, Humphreys PD, Wagner ER, Yuki N, Furukawa K, Furukawa K, Plomp JJ, Willison HJ (2005) Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy. J Neurosci 25, 1620-1628.
24. Greenshields KN, Halstead SK, Zitman FM, Rinaldi S, Bren-nan KM, O'Leary C, Chamberlain LH, Easton A, Roxburgh J, Pediani J, Furukawa K, Furukawa K, Goodyear CS, Plomp JJ, Willison HJ (2009) The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice. J Clin Invest 119, 595-610.